Italy’s private equity weekly roundup. News from VivaTicket, Valedo, Cristallina, Bormioli Pharma, Giannico, Farmol, Agritre, MP Invest, Spactiv, Ferretti, Azimut Benetti, Sanlorenzo, CFO sim, Brera advisory

Bahrein’s Investcorp announced the acquisition of Vivaticket, an Italian ticketing company (see here a previous post by BeBeez). The fund acquired the asset from founders Luca Montebugnoli and Luana Sabattini, Giuseppe Camillo Pilenga, Stefano Landi, and Bravo Capital Partners. IPE (Investimenti in Private Equity), the investment holding Italian businessman Gianfilippo Cuneo and other investors, acquired a controlling stake in Valedo, a bartering company for the distribution of OTC drugs, from the founder Carlo Santoro who will hold a minority of the business and his chairman and ceo role (see here a previous post by BeBeez). In October Carlo Paolo Grossi will be in charge as ceo. Valedo has sales of 125 million euros